Literature DB >> 21763478

Differential roles of CCN family proteins during osteoblast differentiation: Involvement of Smad and MAPK signaling pathways.

Harumi Kawaki1, Satoshi Kubota, Akiko Suzuki, Makoto Suzuki, Kumiko Kohsaka, Kenji Hoshi, Toshiya Fujii, Noureddine Lazar, Toshihiro Ohgawara, Takeyasu Maeda, Bernard Perbal, Teruko Takano-Yamamoto, Masaharu Takigawa.   

Abstract

CCN family proteins play diverse roles in many aspects of cellular processes such as proliferation, differentiation, adhesion, migration, angiogenesis and survival. In the bone tissue of vertebrate species, the expression of most CCN family members has been observed in osteoblasts. However, their spatial and temporal distributions, as well as their functions, are still only partially understood. In this study, we evaluated the localization of CCN family members in skeletal tissue in vivo and comparatively analyzed the gene expression patterns and functions of the members in murine osteoblasts in primary culture. Immunofluorescent analyses revealed that the CCN family members were differentially produced in osteoblasts and osteocytes. The presence of all Ccn transcripts was confirmed in those osteoblasts. Among the members, CCN1, CCN2, CCN4 and CCN5 were found in osteocytes. CCN4 and CCN5 were distributed in osteocytes located inside of bone matrix as well. Next, we investigated the expression pattern of Ccn family members during osteoblast differentiation. Along with differentiation, most of the members followed proper gene expression patterns; whereas, Ccn4 and Ccn5 showed quite similar patterns. Furthermore, we evaluated the effects of CCN family members on the osteoblastic activities by using recombinant CCN proteins and RNA interference method. Five members of this family displayed positive effects on osteoblast proliferation or differentiation. Of note, CCN3 drastically inhibited the osteoblast activities. Each Ccn specific siRNA could modulate osteoblast activities in a manner expected by the observed effect of respective recombinant CCN protein. In addition, we found that extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinase pathways were critically involved in the CCN family member-mediated modification of osteoblast activities. Collectively, all Ccn family members were found to be differentially expressed along with differentiation and therefore could participate in progression of the osteoblast lineage.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763478     DOI: 10.1016/j.bone.2011.06.033

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  30 in total

1.  The official unified nomenclature adopted by the HGNC calls for the use of the acronyms, CCN1-6, and discontinuation in the use of CYR61, CTGF, NOV and WISP 1-3 respectively.

Authors:  Bernard Perbal; Susan Tweedie; Elspeth Bruford
Journal:  J Cell Commun Signal       Date:  2018-11-05       Impact factor: 5.782

2.  YAP and TAZ Mediate Osteocyte Perilacunar/Canalicular Remodeling.

Authors:  Christopher D Kegelman; Jennifer C Coulombe; Kelsey M Jordan; Daniel J Horan; Ling Qin; Alexander G Robling; Virginia L Ferguson; Teresita M Bellido; Joel D Boerckel
Journal:  J Bone Miner Res       Date:  2019-10-14       Impact factor: 6.741

3.  CCN3 protein participates in bone regeneration as an inhibitory factor.

Authors:  Yuki Matsushita; Kei Sakamoto; Yoshihiro Tamamura; Yasuaki Shibata; Tokutaro Minamizato; Tasuku Kihara; Masako Ito; Ken-ichi Katsube; Shuichi Hiraoka; Haruhiko Koseki; Kiyoshi Harada; Akira Yamaguchi
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

4.  Connective tissue growth factor (CTGF/CCN2) negatively regulates BMP-2 induced osteoblast differentiation and signaling.

Authors:  Christina Mundy; Maureen Gannon; Steven N Popoff
Journal:  J Cell Physiol       Date:  2014-05       Impact factor: 6.384

5.  CCN3: a novel anti-fibrotic treatment in end-stage renal disease?

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2012-03-16       Impact factor: 5.782

6.  Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family.

Authors:  Tarek Abd El Kader; Satoshi Kubota; Danilo Janune; Takashi Nishida; Takako Hattori; Eriko Aoyama; Bernard Perbal; Takuo Kuboki; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2012-10-14       Impact factor: 5.782

7.  WNT1-induced Secreted Protein-1 (WISP1), a Novel Regulator of Bone Turnover and Wnt Signaling.

Authors:  Azusa Maeda; Mitsuaki Ono; Kenn Holmbeck; Li Li; Tina M Kilts; Vardit Kram; Megan L Noonan; Yuya Yoshioka; Erin M B McNerny; Margaret A Tantillo; David H Kohn; Karen M Lyons; Pamela G Robey; Marian F Young
Journal:  J Biol Chem       Date:  2015-04-11       Impact factor: 5.157

8.  Structural analyses of von Willebrand factor C domains of collagen 2A and CCN3 reveal an alternative mode of binding to bone morphogenetic protein-2.

Authors:  Emma-Ruoqi Xu; Emily E Blythe; Gerhard Fischer; Marko Hyvönen
Journal:  J Biol Chem       Date:  2017-06-05       Impact factor: 5.157

9.  Transforming growth factor β1 regulates the expression of CCN2 in human keratinocytes via Smad-ERK signalling.

Authors:  Elizabeth Kiwanuka; Johan Pe Junker; Elof Eriksson
Journal:  Int Wound J       Date:  2017-03-29       Impact factor: 3.315

Review 10.  Molecular regulation of CCN2 in the intervertebral disc: lessons learned from other connective tissues.

Authors:  Cassie M Tran; Irving M Shapiro; Makarand V Risbud
Journal:  Matrix Biol       Date:  2013-04-06       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.